US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pyxis Oncology, Inc.

1.10

-0.0800-6.78%

Post-market: 1.170.0700+6.36%18:56 EDT

Volume:6.62M

Turnover:7.31M

Market Cap:68.14M

PE:-0.70

High:1.22

Open:1.21

Low:1.10

Close:1.18

Loading ...

Overview Company News Filings

Pyxis Oncology Inc. Conducted Annual Stockholder Meeting Virtually

Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Globus Medical (GMED) and Ramsay Health Care (OtherRMSYF)

Promising Developments and Risk-Reward Profile Justify Buy Rating for Pyxis Oncology

Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Pyxis Oncology Q1 EPS $(0.35) Misses $(0.29) Estimate

Pyxis Oncology Reports Q1 2025 Results: Net Loss Widens to $21.2M, EPS at ($0.35) Amid Absence of Prior Year One-Time Revenue

BRIEF-Pyxis Oncology Q1 Net Income USD -21.158 Million

Pyxis Oncology Q1 Basic EPS USD -0.35

THOMSON REUTERS

Pyxis Oncology Inc - Expects Cash Runway Into Second Half of 2026

THOMSON REUTERS

Press Release: Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update

Pyxis Oncology Inc. to Participate in RBC Capital Markets Global Healthcare Conference

Pyxis Oncology Inc expected to post a loss of 29 cents a share - Earnings Preview

William Blair Sticks to Their Hold Rating for Pyxis Oncology (PYXS)

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate

MT Newswires Live

Pyxis Oncology Highlights Strategic Focus on Lead Candidate

Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus

Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PYXS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","market":"US","secType":"STK","nameCN":"Pyxis Oncology, Inc.","latestPrice":1.1,"timestamp":1751054400000,"preClose":1.18,"halted":0,"volume":6619486,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.1,"latestTime":"18:56 EDT","volume":1967817,"amount":2164877.859856,"timestamp":1751065012489},"delay":0,"floatShares":44649355,"shares":61947665,"eps":-1.564128,"marketStatus":"Market Closed","change":-0.08,"latestTime":"06-27 16:00:00 EDT","open":1.21,"high":1.22,"low":1.1,"amount":7314714.727813601,"amplitude":0.101695,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.564128,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":1.18,"preHourTrading":{"tag":"盘前","latestPrice":1.2001,"preClose":1.18,"latestTime":"08:46 EDT","volume":466,"amount":550.3761968,"timestamp":1751028411102},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.1,"latestTime":"18:56 EDT","volume":1967817,"amount":2164877.859856,"timestamp":1751065012489},"volumeRatio":16.267773720003348,"impliedVol":0.8787,"impliedVolPercentile":0.556},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","floatShares":44649355,"roa":"-29.19%","roe":"-66.30%","lyrEps":-1.323124,"volumeRatio":16.267773720003348,"shares":61947665,"dividePrice":0,"high":1.22,"amplitude":0.101695,"preClose":1.18,"low":1.1,"week52Low":0.8332,"pbRate":"0.66","week52High":5.3899,"institutionHeld":0,"latestPrice":1.1,"eps":-1.564128,"divideRate":0,"volume":6619486,"delay":0,"ttmEps":-1.564128,"open":1.21,"prevYearClose":1.56,"prevWeekClose":1.17,"prevMonthClose":1.21,"prevQuarterClose":0.9799,"fiveDayClose":1.17,"twentyDayClose":1.25,"sixtyDayClose":0.915},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYXS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544845188","title":"Pyxis Oncology Inc. Conducted Annual Stockholder Meeting Virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2544845188","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544845188?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:18","pubTimestamp":1750277898,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc. held its Annual Meeting of Stockholders on June 18, 2025, in a virtual format. During the meeting, Dr. Santhosh Palani, Mr. Darren Cline, and Dr. Rachel Humphrey were elected as Class I Directors. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL7tBMgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2539520243","title":"Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2539520243","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539520243?lang=en_us&edition=fundamental","pubTime":"2025-05-31 11:52","pubTimestamp":1748663549,"startTime":"0","endTime":"0","summary":"Pyxis Oncology, Inc. ( ($PYXS) ) has released its Q1 earnings. Here is a breakdown of the information Pyxis Oncology, Inc. presented to its investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-reports-increased-losses-amidst-ongoing-rd-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-reports-increased-losses-amidst-ongoing-rd-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2536805650","title":"Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Globus Medical (GMED) and Ramsay Health Care (OtherRMSYF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536805650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536805650?lang=en_us&edition=fundamental","pubTime":"2025-05-20 09:50","pubTimestamp":1747705822,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS – Research Report), Globus Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pyxis-oncology-pyxs-globus-medical-gmed-and-ramsay-health-care-otherrmsyf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pyxis-oncology-pyxs-globus-medical-gmed-and-ramsay-health-care-otherrmsyf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4139","BK4082","PYXS","IE0009354923.USD","GMED","LU2065732104.USD"],"gpt_icon":0},{"id":"2536639382","title":"Promising Developments and Risk-Reward Profile Justify Buy Rating for Pyxis Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2536639382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536639382?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:05","pubTimestamp":1747670711,"startTime":"0","endTime":"0","summary":"Jeffrey La Rosa, an analyst from Leerink Partners, maintained the Buy rating on Pyxis Oncology (PYXS – Research Report). The associated price targe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-and-risk-reward-profile-justify-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-and-risk-reward-profile-justify-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2536068595","title":"Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536068595","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536068595?lang=en_us&edition=fundamental","pubTime":"2025-05-19 19:05","pubTimestamp":1747652700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYXS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 07:05 ET (11:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2535463518","title":"Pyxis Oncology Q1 EPS $(0.35) Misses $(0.29) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535463518","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535463518?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:10","pubTimestamp":1747307459,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Q1 EPS $(0.35) Misses $(0.29) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45432603/pyxis-oncology-q1-eps-0-35-misses-0-29-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2535622845","title":"Pyxis Oncology Reports Q1 2025 Results: Net Loss Widens to $21.2M, EPS at ($0.35) Amid Absence of Prior Year One-Time Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2535622845","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535622845?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:00","pubTimestamp":1747306850,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Reports Q1 2025 Results: Net Loss Widens to $21.2M, EPS at  Amid Absence of Prior Year One-Time Revenue. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on May 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDLL2NLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","NDAQ"],"gpt_icon":1},{"id":"2535845624","title":"BRIEF-Pyxis Oncology Q1 Net Income USD -21.158 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535845624","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535845624?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:00","pubTimestamp":1747306846,"startTime":"0","endTime":"0","summary":"BRIEF-Pyxis Oncology Q1 Net Income USD -21.158 Million\n\n\nMay 15 (Reuters) - Pyxis Oncology Q1 income from operations USD -22.914 million.\n\nQ1 basic EPS USD -0.35","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX64EAE3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2535845588","title":"Pyxis Oncology Q1 Basic EPS USD -0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2535845588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535845588?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:00","pubTimestamp":1747306801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX64EAE3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2535684546","title":"Pyxis Oncology Inc - Expects Cash Runway Into Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2535684546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535684546?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:00","pubTimestamp":1747306801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX64EAE3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2535845422","title":"Press Release: Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535845422","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535845422?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:00","pubTimestamp":1747306800,"startTime":"0","endTime":"0","summary":"- Announced robust preclinical data supporting the unique three-pronged mechanism of action of micvotabart pelidotin , driving anti-tumor activity via direct tumor killing, bystander effect and immunogenic cell death. - On track to report preliminary data from Phase 1 monotherapy expansion cohorts of MICVO for 2L/3L R/M HNSCC patients who have received prior platinum-based chemotherapy and prior PD-1 inhibitor therapy in second half of 2025, and 2L/3L R/M HNSCC patients who have received prior EGFRi and PD-1 inhibitor therapy in first half of 2026. - On track to report preliminary data from Phase 1 trial of MICVO in combination with pembrolizumab targeting multiple tumor types including 1L/2L HNSCC patients in second half of 2025. - Expected cash runway through data milestones and into second half of 2026. BOSTON, May 15, 2025  -- Pyxis Oncology, Inc. , a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, today reported financial results ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4107","LU0053666078.USD","BK4022","BK4588","BK4232","R","L","BK4139","BK4585"],"gpt_icon":0},{"id":"2535028996","title":"Pyxis Oncology Inc. to Participate in RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2535028996","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535028996?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:30","pubTimestamp":1747222216,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc., a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, will participate in the 2025 RBC Capital Markets Global Healthcare Conference in New York, NY on Wednesday, May 21 at 2:05 p.m. ET. Lara S. Sullivan, M.D., President, Chief Executive Officer and Chief Medical Officer, will participate in fireside chats and be available for one-on-one meetings with investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL9WVppj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4139","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4585","IE00BKPKM429.USD","BK4112","ADCT","BK4505","LU2210150020.SGD","IE00B64PRP62.GBP","LU2095319765.USD","PYXS"],"gpt_icon":0},{"id":"2534143168","title":"Pyxis Oncology Inc  expected to post a loss of 29 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534143168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534143168?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:13","pubTimestamp":1746803585,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc  expected to post a loss of29cents a share - Earnings Preview Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show a fall in quarterly revenue when it reports  results on May 12 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2530239189","title":"William Blair Sticks to Their Hold Rating for Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530239189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530239189?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:25","pubTimestamp":1745853911,"startTime":"0","endTime":"0","summary":"In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Pyxis Oncology (PYXS – Research Report). The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-pyxis-oncology-pyxs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-pyxis-oncology-pyxs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2530168669","title":"Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2530168669","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530168669?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:17","pubTimestamp":1745601420,"startTime":"0","endTime":"0","summary":"Gene signatures associated with increased efficacy of micvotabart pelidotin  due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders. Mouse analog of MICVO in a syngeneic model indicated strong activity of the cytotoxic Auristatin0101 payload and potential for MICVO monotherapy to drive immunogenic cell death, a key hypothesis for MICVO’s mechanism. Combination of a mouse analog of MICVO and anti-PD-1 therapy in a syngeneic model resulted in enhanced tumor clearance and longer immunological memory compared to either treatment alone. Totality of pre-clinical data presented at AACR 2025 strongly support MICVO’s unique, three-pronged mechanism of action of driving anti-tumor activity via direct tumor killing, bystander effect and immunogenic cell death, further reinforcing the potential patient benefit for MICVO as a monotherapy and in combination with an anti-PD-1 therapy. Key findings from preclinical studies of MICV","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pyxis-oncology-presents-promising-preclinical-171700556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014575.USD","BK4559","LU0965509101.SGD","LU0320765646.SGD","BK4533","LU1941712264.USD","IE00BBT3K403.USD","LU0006306889.USD","LU0070302665.USD","BK4550","LU1291159041.SGD","LU1430594728.SGD","LU0058720904.USD","LU0106261372.USD","LU1941712348.USD","LU2089984988.USD","LU0211331839.USD","IE00B1BXHZ80.USD","LU2023250843.SGD","LU0985320562.USD","MRK","LU0965509010.AUD","LU0861579265.USD","LU2112291526.USD","SG9999001176.USD","LU2324357040.USD","LU1066051225.USD","LU0965509283.SGD","LU2361044865.SGD","IE0009355771.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2361044949.HKD","ADC","LU0266013472.USD","LU2361045086.USD","BK4007","SG9999014542.SGD","L","LU0203345920.USD","LU0238689110.USD","LU1585245621.USD","SG9999002224.SGD","LU1116320901.HKD","PACI.U","IE00BJT1NW94.SGD","PYXS","LU1069347547.HKD"],"gpt_icon":0},{"id":"2527225559","title":"Top Cancer Stocks to Buy to Boost Your Portfolio's Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2527225559","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527225559?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:45","pubTimestamp":1744811100,"startTime":"0","endTime":"0","summary":"An updated edition of the March 7, 2025, article.The cancer market is seeing significant growth and evolution as there is a rising demand for targeted, less toxic cancer medicines. According to the American Cancer Society, 2024 was the first time that new cancer cases in the United States were expected to cross the 2-million mark. This resulted in a massive increase in the global spending on cancer medicines.Verastem Oncology’s new drug application  seeking approval of its novel combination regimen of avutometinib plus defactinib for treating KRAS mutant recurrent low-grade serous ovarian cancer , a rare and distinct type of ovarian cancer, is under priority review with the FDA. The FDA’s decision on the NDA is expected on June 30, 2025. Avutometinib is an RAF/M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-cancer-stocks-buy-boost-134500112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","LU1244550221.USD","LU1934455863.HKD","LU1057294990.SGD","LU0912757837.SGD","LU0456855351.SGD","LU0795875086.SGD","LU0029864427.USD","BK4550","LU0203347892.USD","AZN","LU0820561818.USD","LU1894683264.USD","LU0321505439.SGD","VSTM","LU1839511570.USD","BK4534","LU1066051498.USD","LU0320765992.SGD","L","LU0310800379.SGD","LU1496350171.SGD","SGXZ57979304.SGD","LU2089984988.USD","LU0868494617.USD","LU0949170772.SGD","IE00BJT1NW94.SGD","LU2462157665.USD","IE00BVYPNW00.USD","LU0203345920.USD","LU0306806265.USD","NVS","RLAY","LU1093756168.USD","LU2417539215.USD","BK4599","LU1496350502.SGD","PYXS","LU2237443622.USD","LU2237443465.HKD","SG9999002232.USD","BK4107","LU1003077747.HKD","MBC","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4588","LU0795875169.SGD","ABBV"],"gpt_icon":1},{"id":"2522836901","title":"Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522836901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522836901?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:38","pubTimestamp":1742938727,"startTime":"0","endTime":"0","summary":"Pyxis Oncology  said Tuesday it will present new preclinical data from its phase 1 study of micvotabart pelidotin, antibody-drug conjugate to treat recurrent and metastatic head and neck squamous cell carcinoma, at the American Association for Cancer Research Meeting in Chicago in April.In phase 1 trial, the drug showed monotherapy effect on multiple tumor types with significant tumor regression, according to the company. It has begun the part 2 monotherapy expansion cohorts of the ongoing Phase 1 to assess Micvo in second-line and third-line recurrent and metastatic head and neck squamous cell carcinoma patients who have received prior platinum and PD-1 inhibitor therapy and those who received prior EGFRi and PD-1 inhibitor therapy.The company added that preliminary data for patients who received prior platinum and PD-1 inhibitor therapy are expected in H2. Preliminary data from those who received prior EGFRi and PD-1 inhibitor therapy are expected in H1 2026.The company said it also ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1066051811.HKD","SGXZ57979304.SGD","LU1116320901.HKD","LU1291159041.SGD","LU2461242641.AUD","LU1983299246.USD","IE00BSNM7G36.USD","IE000M9KFDE8.USD","BK4550","SG9999014559.SGD","IE0002141913.USD","LU0266013472.USD","LU1037948541.HKD","LU1974910355.USD","MRK","PYXS","SG9999001176.USD","LU0058720904.USD","LU1066053197.SGD","LU1585245621.USD","LU1037948897.HKD","LU1699723380.USD","LU2361044949.HKD","LU1989771016.USD","SG9999014575.USD","LU0208291251.USD","SG9999015358.SGD","LU0070302665.USD","BK4007","IE00BFTCPJ56.SGD","LU1917777945.USD","LU0265550946.USD","LU1929549753.HKD","LU1934455863.HKD","LU0211331839.USD","IE00BBT3K403.USD","LU0203345920.USD","LU1035773651.USD","LU0320765489.SGD","IE00BLSP4239.USD","LU1066051498.USD","SG9999002224.SGD","LU2106854487.HKD","LU0965509010.AUD","BK4516","LU1941712264.USD","BK4588","LU1093756325.SGD","LU2023250504.SGD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2521747557","title":"Pyxis Oncology Highlights Strategic Focus on Lead Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747557?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:57","pubTimestamp":1742817443,"startTime":"0","endTime":"0","summary":"Pyxis Oncology ( ($PYXS) ) has issued an update. On March 24, 2025, Pyxis Oncology updated its corporate presentation, highlighting its focus on ad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520186904","title":"Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186904?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:15","pubTimestamp":1742386543,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sean Lee from Citi maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with a price target of $5.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2520183208","title":"Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183208?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:45","pubTimestamp":1742384741,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on PYXS stock, giving a Buy rating yesterday. Sam Slutsky has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"PYXS","fiscalQuarterEnding":"2025/03","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-18","symbol":"PYXS","fiscalQuarterEnding":"2024/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-12","symbol":"PYXS","fiscalQuarterEnding":"2024/09","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-08-14","symbol":"PYXS","fiscalQuarterEnding":"2024/06","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2024-05-14","symbol":"PYXS","fiscalQuarterEnding":"2024/03","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PYXS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1732248000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PYXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PYXS","date":"2025-06-27","current":-0.767573,"percent":0.806381,"low":-8.295353,"twenty":-3.551123,"median":-1.083246,"eighty":-0.771062,"high":-0.361135,"avg":-1.994938,"sd":1.718677,"marketCap":73098244},"quantilePoints":[{"date":"2021-10-08","current":-8.027761,"twenty":-7.000853,"median":-5.460491,"eighty":-3.942431,"marketCap":423392125},{"date":"2021-10-15","current":-7.158087,"twenty":-7.278503,"median":-7.179372,"eighty":-6.139529,"marketCap":377524644},{"date":"2021-10-22","current":-7.924373,"twenty":-7.797875,"median":-7.194576,"eighty":-7.01456,"marketCap":417939347},{"date":"2021-10-29","current":-8.112904,"twenty":-7.957214,"median":-7.453046,"eighty":-7.096054,"marketCap":427882647},{"date":"2021-11-05","current":-7.346617,"twenty":-8.064251,"median":-7.83923,"eighty":-7.160519,"marketCap":387467944},{"date":"2021-11-12","current":-7.188495,"twenty":-8.027761,"median":-7.453046,"eighty":-7.150789,"marketCap":379128403},{"date":"2021-11-19","current":-6.530285,"twenty":-8.0083,"median":-7.297964,"eighty":-6.572742,"marketCap":416142385},{"date":"2021-11-26","current":-6.489849,"twenty":-7.968161,"median":-7.194576,"eighty":-6.360457,"marketCap":413565652},{"date":"2021-12-03","current":-6.161313,"twenty":-7.92194,"median":-7.161128,"eighty":-6.269642,"marketCap":392629696},{"date":"2021-12-10","current":-4.599504,"twenty":-7.909777,"median":-7.054699,"eighty":-6.108748,"marketCap":293103383},{"date":"2021-12-17","current":-4.29624,"twenty":-7.887883,"median":-6.583356,"eighty":-5.099226,"marketCap":273777885},{"date":"2021-12-23","current":-4.958366,"twenty":-7.83923,"median":-6.472159,"eighty":-4.735973,"marketCap":315971889},{"date":"2021-12-31","current":-5.544677,"twenty":-7.608128,"median":-6.388761,"eighty":-4.857278,"marketCap":353334518},{"date":"2022-01-07","current":-5.104944,"twenty":-7.510822,"median":-6.288084,"eighty":-4.857278,"marketCap":325312546},{"date":"2022-01-14","current":-5.206032,"twenty":-7.39527,"median":-6.161313,"eighty":-4.872441,"marketCap":331754378},{"date":"2022-01-21","current":-4.811789,"twenty":-7.356348,"median":-6.100661,"eighty":-4.857278,"marketCap":306631231},{"date":"2022-01-28","current":-4.25075,"twenty":-7.307695,"median":-5.81256,"eighty":-4.84818,"marketCap":270879060},{"date":"2022-02-04","current":-4.321512,"twenty":-7.259042,"median":-5.504241,"eighty":-4.792582,"marketCap":275388343},{"date":"2022-02-11","current":-3.811017,"twenty":-7.205523,"median":-5.368642,"eighty":-4.623765,"marketCap":242857089},{"date":"2022-02-18","current":-3.654331,"twenty":-7.189711,"median":-5.206032,"eighty":-4.399349,"marketCap":232872248},{"date":"2022-02-25","current":-3.159,"twenty":-7.173899,"median":-5.104944,"eighty":-4.333642,"marketCap":201307268},{"date":"2022-03-04","current":-2.22899,"twenty":-7.160519,"median":-5.074618,"eighty":-4.262881,"marketCap":142042408},{"date":"2022-03-11","current":-2.330078,"twenty":-7.150789,"median":-5.00891,"eighty":-4.128434,"marketCap":148484241},{"date":"2022-03-18","current":-2.754648,"twenty":-7.091189,"median":-4.948257,"eighty":-3.780691,"marketCap":175539938},{"date":"2022-03-25","current":-2.375568,"twenty":-7.01456,"median":-4.892659,"eighty":-3.269185,"marketCap":151383066},{"date":"2022-04-01","current":-1.514143,"twenty":-6.776977,"median":-4.864859,"eighty":-2.912659,"marketCap":115037013},{"date":"2022-04-08","current":-1.594728,"twenty":-6.572742,"median":-4.821897,"eighty":-2.615147,"marketCap":121159431},{"date":"2022-04-14","current":-1.548073,"twenty":-6.514111,"median":-4.811789,"eighty":-2.474634,"marketCap":117614873},{"date":"2022-04-22","current":-1.246941,"twenty":-6.475697,"median":-4.756191,"eighty":-2.394775,"marketCap":94736363},{"date":"2022-04-29","current":-1.038157,"twenty":-6.428186,"median":-4.62983,"eighty":-2.330078,"marketCap":78873989},{"date":"2022-05-06","current":-0.961884,"twenty":-6.388761,"median":-4.480726,"eighty":-2.254263,"marketCap":73079165},{"date":"2022-05-13","current":-0.86541,"twenty":-6.374609,"median":-4.387219,"eighty":-1.911128,"marketCap":61037378},{"date":"2022-05-20","current":-0.951094,"twenty":-6.339557,"median":-4.33162,"eighty":-1.594728,"marketCap":67080683},{"date":"2022-05-27","current":-1.066768,"twenty":-6.294231,"median":-4.29624,"eighty":-1.532805,"marketCap":75239144},{"date":"2022-06-03","current":-1.0582,"twenty":-6.247238,"median":-4.25075,"eighty":-1.347884,"marketCap":74634814},{"date":"2022-06-10","current":-1.02821,"twenty":-6.197705,"median":-4.190098,"eighty":-1.189259,"marketCap":72519657},{"date":"2022-06-17","current":-1.015357,"twenty":-6.15727,"median":-4.04352,"eighty":-1.12564,"marketCap":71613161},{"date":"2022-06-24","current":-1.002505,"twenty":-6.141096,"median":-3.811017,"eighty":-1.072056,"marketCap":70706666},{"date":"2022-07-01","current":-1.045347,"twenty":-6.100661,"median":-3.677076,"eighty":-1.066768,"marketCap":73728318},{"date":"2022-07-08","current":-1.182442,"twenty":-6.096617,"median":-3.260088,"eighty":-1.066768,"marketCap":83397606},{"date":"2022-07-15","current":-1.27241,"twenty":-5.897474,"median":-3.073075,"eighty":-1.066768,"marketCap":89743076},{"date":"2022-07-22","current":-1.203863,"twenty":-5.791331,"median":-2.820355,"eighty":-1.066768,"marketCap":84908432},{"date":"2022-07-29","current":-1.135315,"twenty":-5.591177,"median":-2.643451,"eighty":-1.070195,"marketCap":80073788},{"date":"2022-08-05","current":-1.195294,"twenty":-5.512328,"median":-2.506983,"eighty":-1.071052,"marketCap":84304101},{"date":"2022-08-12","current":-1.250989,"twenty":-5.504241,"median":-2.451384,"eighty":-1.071855,"marketCap":88232250},{"date":"2022-08-19","current":-1.008852,"twenty":-5.469241,"median":-2.395786,"eighty":-1.066768,"marketCap":88724535},{"date":"2022-08-26","current":-0.940916,"twenty":-5.313533,"median":-2.360405,"eighty":-1.061627,"marketCap":82749819},{"date":"2022-09-02","current":-0.930726,"twenty":-5.276793,"median":-2.314915,"eighty":-1.048774,"marketCap":81853611},{"date":"2022-09-09","current":-0.913742,"twenty":-5.234336,"median":-2.292171,"eighty":-1.039901,"marketCap":80359932},{"date":"2022-09-16","current":-0.750695,"twenty":-5.145379,"median":-2.22899,"eighty":-1.023926,"marketCap":66020614},{"date":"2022-09-23","current":-0.655584,"twenty":-5.104944,"median":-1.912825,"eighty":-1.019402,"marketCap":57656011},{"date":"2022-09-30","current":-0.669171,"twenty":-5.092813,"median":-1.713484,"eighty":-1.014114,"marketCap":58850954},{"date":"2022-10-07","current":-0.65041,"twenty":-5.081694,"median":-1.594728,"eighty":-1.005075,"marketCap":57200979},{"date":"2022-10-14","current":-0.617524,"twenty":-5.073607,"median":-1.548073,"eighty":-0.983479,"marketCap":54308795},{"date":"2022-10-21","current":-0.61387,"twenty":-5.069563,"median":-1.480212,"eighty":-0.968263,"marketCap":53987441},{"date":"2022-10-28","current":-0.68695,"twenty":-5.033171,"median":-1.314802,"eighty":-0.940828,"marketCap":60414518},{"date":"2022-11-04","current":-0.484681,"twenty":-4.978584,"median":-1.27452,"eighty":-0.92665,"marketCap":49168502},{"date":"2022-11-11","current":-0.47201,"twenty":-4.952301,"median":-1.27241,"eighty":-0.914661,"marketCap":47883051},{"date":"2022-11-18","current":-0.443499,"twenty":-4.948257,"median":-1.248965,"eighty":-0.896339,"marketCap":44990786},{"date":"2022-11-25","current":-0.481514,"twenty":-4.926018,"median":-1.240279,"eighty":-0.882491,"marketCap":48847139},{"date":"2022-12-02","current":-0.438748,"twenty":-4.892659,"median":-1.220999,"eighty":-0.86541,"marketCap":44508742},{"date":"2022-12-09","current":-0.392814,"twenty":-4.884572,"median":-1.212431,"eighty":-0.769717,"marketCap":39848982},{"date":"2022-12-16","current":-0.367471,"twenty":-4.872441,"median":-1.195294,"eighty":-0.689873,"marketCap":37278080},{"date":"2022-12-23","current":-0.405485,"twenty":-4.866376,"median":-1.17864,"eighty":-0.672428,"marketCap":41134433},{"date":"2022-12-30","current":-0.424492,"twenty":-4.857278,"median":-1.172214,"eighty":-0.663737,"marketCap":43062609},{"date":"2023-01-06","current":-0.459339,"twenty":-4.857278,"median":-1.165305,"eighty":-0.655584,"marketCap":46597600},{"date":"2023-01-13","current":-0.484681,"twenty":-4.821897,"median":-1.161021,"eighty":-0.65041,"marketCap":49168502},{"date":"2023-01-20","current":-0.503688,"twenty":-4.817854,"median":-1.148168,"eighty":-0.637308,"marketCap":51096678},{"date":"2023-01-27","current":-0.503688,"twenty":-4.8128,"median":-1.133871,"eighty":-0.620447,"marketCap":51096678},{"date":"2023-02-03","current":-0.510024,"twenty":-4.807745,"median":-1.10961,"eighty":-0.601446,"marketCap":51739404},{"date":"2023-02-10","current":-0.478346,"twenty":-4.782473,"median":-1.075336,"eighty":-0.518894,"marketCap":48525776},{"date":"2023-02-17","current":-0.535367,"twenty":-4.74406,"median":-1.071052,"eighty":-0.515093,"marketCap":54310306},{"date":"2023-02-24","current":-0.715935,"twenty":-4.699581,"median":-1.066768,"eighty":-0.51636,"marketCap":72627983},{"date":"2023-03-03","current":-0.719102,"twenty":-4.648026,"median":-1.066768,"eighty":-0.518261,"marketCap":72949346},{"date":"2023-03-10","current":-0.56071,"twenty":-4.611634,"median":-1.062484,"eighty":-0.521429,"marketCap":56881208},{"date":"2023-03-17","current":-0.874327,"twenty":-4.569178,"median":-1.053916,"eighty":-0.530299,"marketCap":88696121},{"date":"2023-03-24","current":-0.621811,"twenty":-4.467079,"median":-1.045347,"eighty":-0.535367,"marketCap":75063167},{"date":"2023-03-31","current":-1.128264,"twenty":-4.406426,"median":-1.049631,"eighty":-0.539965,"marketCap":136200588},{"date":"2023-04-06","current":-1.0326,"twenty":-4.396317,"median":-1.049631,"eighty":-0.550102,"marketCap":124652408},{"date":"2023-04-14","current":-0.996023,"twenty":-4.375089,"median":-1.049631,"eighty":-0.561512,"marketCap":120236928},{"date":"2023-04-21","current":-0.93131,"twenty":-4.350827,"median":-1.045347,"eighty":-0.564447,"marketCap":112424924},{"date":"2023-04-28","current":-0.796256,"twenty":-4.333642,"median":-1.038157,"eighty":-0.578468,"marketCap":96121612},{"date":"2023-05-05","current":-0.83137,"twenty":-4.313425,"median":-1.028722,"eighty":-0.598523,"marketCap":100360456},{"date":"2023-05-12","current":-0.880615,"twenty":-4.299272,"median":-1.023926,"eighty":-0.605036,"marketCap":106305152},{"date":"2023-05-19","current":-1.116393,"twenty":-4.286131,"median":-1.028722,"eighty":-0.610485,"marketCap":121217968},{"date":"2023-05-26","current":-0.929527,"twenty":-4.262881,"median":-1.029233,"eighty":-0.615332,"marketCap":100927993},{"date":"2023-06-02","current":-0.990896,"twenty":-4.248728,"median":-1.023926,"eighty":-0.617524,"marketCap":107591516},{"date":"2023-06-09","current":-0.889112,"twenty":-4.231543,"median":-1.019642,"eighty":-0.617565,"marketCap":96539820},{"date":"2023-06-16","current":-0.904081,"twenty":-4.19313,"median":-1.019043,"eighty":-0.617984,"marketCap":98165069},{"date":"2023-06-23","current":-0.814271,"twenty":-4.185043,"median":-1.018532,"eighty":-0.618997,"marketCap":88413572},{"date":"2023-06-30","current":-0.773857,"twenty":-4.071825,"median":-1.015357,"eighty":-0.620742,"marketCap":84025399},{"date":"2023-07-07","current":-0.724462,"twenty":-4.04352,"median":-1.008852,"eighty":-0.621558,"marketCap":78662075},{"date":"2023-07-14","current":-0.832233,"twenty":-4.001063,"median":-1.004647,"eighty":-0.623624,"marketCap":90363872},{"date":"2023-07-21","current":-0.769367,"twenty":-3.875713,"median":-0.998221,"eighty":-0.627024,"marketCap":83537824},{"date":"2023-07-28","current":-0.82668,"twenty":-3.765527,"median":-0.993459,"eighty":-0.629636,"marketCap":89760926},{"date":"2023-08-04","current":-0.868894,"twenty":-3.713973,"median":-0.985075,"eighty":-0.631445,"marketCap":94344463},{"date":"2023-08-11","current":-0.851305,"twenty":-3.672527,"median":-0.976564,"eighty":-0.632998,"marketCap":92434656},{"date":"2023-08-18","current":-0.898223,"twenty":-3.445079,"median":-0.976328,"eighty":-0.635471,"marketCap":88851359},{"date":"2023-08-25","current":-0.935024,"twenty":-3.25099,"median":-0.975262,"eighty":-0.637855,"marketCap":92491636},{"date":"2023-08-31","current":-0.935024,"twenty":-3.192359,"median":-0.973294,"eighty":-0.638939,"marketCap":92491636},{"date":"2023-09-08","current":-0.943887,"twenty":-3.141815,"median":-0.974334,"eighty":-0.640637,"marketCap":93368334},{"date":"2023-09-15","current":-0.966044,"twenty":-3.044538,"median":-0.974596,"eighty":-0.646397,"marketCap":95560079},{"date":"2023-09-22","current":-0.771062,"twenty":-2.921525,"median":-0.969731,"eighty":-0.650765,"marketCap":76272724},{"date":"2023-09-29","current":-0.904004,"twenty":-2.859779,"median":-0.965073,"eighty":-0.652187,"marketCap":89423193},{"date":"2023-10-06","current":-0.89071,"twenty":-2.744539,"median":-0.959532,"eighty":-0.652265,"marketCap":88108146},{"date":"2023-10-13","current":-0.864122,"twenty":-2.691973,"median":-0.95275,"eighty":-0.652875,"marketCap":85478053},{"date":"2023-10-20","current":-0.771062,"twenty":-2.629299,"median":-0.948916,"eighty":-0.654368,"marketCap":76272724},{"date":"2023-10-27","current":-0.691297,"twenty":-2.600994,"median":-0.945798,"eighty":-0.654976,"marketCap":68382442},{"date":"2023-11-03","current":-0.771062,"twenty":-2.545396,"median":-0.940916,"eighty":-0.655584,"marketCap":76272724},{"date":"2023-11-10","current":-0.697312,"twenty":-2.502939,"median":-0.938487,"eighty":-0.655584,"marketCap":65752348},{"date":"2023-11-17","current":-0.690685,"twenty":-2.474634,"median":-0.935024,"eighty":-0.65966,"marketCap":65127425},{"date":"2023-11-24","current":-0.728273,"twenty":-2.460482,"median":-0.935024,"eighty":-0.665095,"marketCap":68671775},{"date":"2023-12-01","current":-0.747067,"twenty":-2.441275,"median":-0.93131,"eighty":-0.669171,"marketCap":70443949},{"date":"2023-12-08","current":-0.977295,"twenty":-2.416003,"median":-0.930726,"eighty":-0.670259,"marketCap":92153091},{"date":"2023-12-15","current":-0.831641,"twenty":-2.396796,"median":-0.924102,"eighty":-0.671891,"marketCap":78418736},{"date":"2023-12-22","current":-0.784655,"twenty":-2.384666,"median":-0.920535,"eighty":-0.672068,"marketCap":73988299},{"date":"2023-12-29","current":-0.841038,"twenty":-2.375568,"median":-0.91698,"eighty":-0.672334,"marketCap":79304824},{"date":"2024-01-05","current":-0.9632,"twenty":-2.36647,"median":-0.920535,"eighty":-0.672474,"marketCap":90823960},{"date":"2024-01-12","current":-1.137046,"twenty":-2.342209,"median":-0.924102,"eighty":-0.674981,"marketCap":107216577},{"date":"2024-01-19","current":-1.021931,"twenty":-2.330078,"median":-0.930127,"eighty":-0.677698,"marketCap":96362006},{"date":"2024-01-26","current":-1.484737,"twenty":-2.317948,"median":-0.93131,"eighty":-0.680936,"marketCap":140001812},{"date":"2024-02-02","current":-1.743157,"twenty":-2.299752,"median":-0.935024,"eighty":-0.68368,"marketCap":164369216},{"date":"2024-02-09","current":-1.743157,"twenty":-2.293687,"median":-0.937011,"eighty":-0.685334,"marketCap":164369216},{"date":"2024-02-16","current":-2.626481,"twenty":-2.299752,"median":-0.940076,"eighty":-0.68714,"marketCap":247661433},{"date":"2024-02-23","current":-2.227106,"twenty":-2.305535,"median":-0.942402,"eighty":-0.688076,"marketCap":210002718},{"date":"2024-03-01","current":-2.988269,"twenty":-2.330078,"median":-0.94771,"eighty":-0.690807,"marketCap":281775799},{"date":"2024-03-08","current":-2.927188,"twenty":-2.389016,"median":-0.951922,"eighty":-0.691889,"marketCap":276016231},{"date":"2024-03-15","current":-2.227106,"twenty":-2.44633,"median":-0.953803,"eighty":-0.694552,"marketCap":210002718},{"date":"2024-03-22","current":-2.978041,"twenty":-2.463514,"median":-0.959532,"eighty":-0.695729,"marketCap":219749680},{"date":"2024-03-28","current":-3.308852,"twenty":-2.5272,"median":-0.963576,"eighty":-0.695729,"marketCap":244160175},{"date":"2024-04-05","current":-4.049404,"twenty":-2.643451,"median":-0.966044,"eighty":-0.696346,"marketCap":298805547},{"date":"2024-04-12","current":-4.151821,"twenty":-2.729849,"median":-0.970206,"eighty":-0.696927,"marketCap":306362886},{"date":"2024-04-19","current":-3.568833,"twenty":-2.927188,"median":-0.974596,"eighty":-0.696927,"marketCap":263344188},{"date":"2024-04-26","current":-3.387634,"twenty":-2.988269,"median":-0.976564,"eighty":-0.697312,"marketCap":249973512},{"date":"2024-05-03","current":-3.5187,"twenty":-3.030555,"median":-0.978065,"eighty":-0.699743,"marketCap":259644879},{"date":"2024-05-10","current":-3.598489,"twenty":-3.143409,"median":-0.983769,"eighty":-0.709023,"marketCap":265532518},{"date":"2024-05-17","current":-4.247436,"twenty":-3.277339,"median":-0.985368,"eighty":-0.709479,"marketCap":245514546},{"date":"2024-05-24","current":-3.890937,"twenty":-3.387634,"median":-0.992012,"eighty":-0.709599,"marketCap":224907809},{"date":"2024-05-31","current":-3.789857,"twenty":-3.432528,"median":-0.994328,"eighty":-0.710926,"marketCap":219065119},{"date":"2024-06-07","current":-3.606477,"twenty":-3.496972,"median":-0.998221,"eighty":-0.713593,"marketCap":208465194},{"date":"2024-06-14","current":-4.024176,"twenty":-3.528275,"median":-1.002505,"eighty":-0.715232,"marketCap":232609468},{"date":"2024-06-21","current":-3.443472,"twenty":-3.544174,"median":-1.006789,"eighty":-0.717202,"marketCap":199043038},{"date":"2024-06-28","current":-3.27028,"twenty":-3.546282,"median":-1.006789,"eighty":-0.718469,"marketCap":189031998},{"date":"2024-07-05","current":-2.934083,"twenty":-3.543661,"median":-1.012249,"eighty":-0.719102,"marketCap":169598802},{"date":"2024-07-12","current":-3.025773,"twenty":-3.528275,"median":-1.017751,"eighty":-0.722318,"marketCap":174898764},{"date":"2024-07-15","current":-3.209153,"twenty":-3.523487,"median":-1.018532,"eighty":-0.72339,"marketCap":185498689},{"date":"2024-08-02","current":-3.759294,"twenty":-3.542637,"median":-1.018787,"eighty":-0.724462,"marketCap":217298465},{"date":"2024-08-09","current":-3.54535,"twenty":-3.542637,"median":-1.01922,"eighty":-0.726748,"marketCap":204931886},{"date":"2024-08-16","current":-3.414893,"twenty":-3.535163,"median":-1.019642,"eighty":-0.728273,"marketCap":202171893},{"date":"2024-08-23","current":-3.633924,"twenty":-3.545198,"median":-1.023926,"eighty":-0.728273,"marketCap":215139186},{"date":"2024-08-30","current":-3.64388,"twenty":-3.568833,"median":-1.028147,"eighty":-0.728273,"marketCap":215728609},{"date":"2024-09-06","current":-3.484584,"twenty":-3.574764,"median":-1.029598,"eighty":-0.728273,"marketCap":206297850},{"date":"2024-09-13","current":-3.623968,"twenty":-3.60454,"median":-1.038157,"eighty":-0.730014,"marketCap":214549764},{"date":"2024-09-20","current":-3.663792,"twenty":-3.616003,"median":-1.045347,"eighty":-0.730587,"marketCap":216907454},{"date":"2024-09-27","current":-3.73382,"twenty":-3.623968,"median":-1.049631,"eighty":-0.732502,"marketCap":221053355},{"date":"2024-10-04","current":-3.52304,"twenty":-3.625864,"median":-1.057271,"eighty":-0.738629,"marketCap":208574536},{"date":"2024-10-11","current":-3.166721,"twenty":-3.623968,"median":-1.062484,"eighty":-0.745662,"marketCap":187479391},{"date":"2024-10-18","current":-3.242,"twenty":-3.616003,"median":-1.065075,"eighty":-0.747504,"marketCap":191936112},{"date":"2024-10-25","current":-3.763932,"twenty":-3.625864,"median":-1.066768,"eighty":-0.747613,"marketCap":222836043},{"date":"2024-10-31","current":-3.784006,"twenty":-3.637906,"median":-1.066768,"eighty":-0.748092,"marketCap":224024502},{"date":"2024-11-08","current":-3.954637,"twenty":-3.663792,"median":-1.071052,"eighty":-0.748411,"marketCap":234126403},{"date":"2024-11-15","current":-4.437354,"twenty":-3.685372,"median":-1.075336,"eighty":-0.749781,"marketCap":254513320},{"date":"2024-11-22","current":-2.177206,"twenty":-3.694157,"median":-1.080597,"eighty":-0.752917,"marketCap":124878030},{"date":"2024-11-29","current":-2.083898,"twenty":-3.693667,"median":-1.083246,"eighty":-0.755737,"marketCap":119526115},{"date":"2024-12-06","current":-1.7625,"twenty":-3.691387,"median":-1.086059,"eighty":-0.758203,"marketCap":101091739},{"date":"2024-12-13","current":-1.575883,"twenty":-3.686241,"median":-1.106883,"eighty":-0.759205,"marketCap":90387908},{"date":"2024-12-20","current":-1.596618,"twenty":-3.67968,"median":-1.116393,"eighty":-0.76056,"marketCap":91577222},{"date":"2024-12-27","current":-1.679559,"twenty":-3.673718,"median":-1.116393,"eighty":-0.762678,"marketCap":96334480},{"date":"2025-01-03","current":-1.752133,"twenty":-3.673597,"median":-1.123944,"eighty":-0.765861,"marketCap":100497082},{"date":"2025-01-10","current":-1.669192,"twenty":-3.665753,"median":-1.128264,"eighty":-0.766468,"marketCap":95739823},{"date":"2025-01-17","current":-1.524045,"twenty":-3.663792,"median":-1.133871,"eighty":-0.766629,"marketCap":87414621},{"date":"2025-01-24","current":-1.700295,"twenty":-3.658115,"median":-1.136181,"eighty":-0.768273,"marketCap":97523795},{"date":"2025-01-31","current":-1.679559,"twenty":-3.64806,"median":-1.148168,"eighty":-0.769367,"marketCap":96334480},{"date":"2025-02-07","current":-1.524045,"twenty":-3.64388,"median":-1.161021,"eighty":-0.770083,"marketCap":87414621},{"date":"2025-02-14","current":-1.347794,"twenty":-3.637906,"median":-1.165305,"eighty":-0.77056,"marketCap":77305447},{"date":"2025-02-21","current":-1.41,"twenty":-3.633924,"median":-1.174839,"eighty":-0.770761,"marketCap":80873391},{"date":"2025-02-28","current":-1.171544,"twenty":-3.633734,"median":-1.174839,"eighty":-0.771062,"marketCap":67196273},{"date":"2025-03-07","current":-1.223383,"twenty":-3.629657,"median":-1.181912,"eighty":-0.771062,"marketCap":70169560},{"date":"2025-03-14","current":-1.109339,"twenty":-3.623968,"median":-1.174839,"eighty":-0.771062,"marketCap":63628330},{"date":"2025-03-21","current":-0.892026,"twenty":-3.623745,"median":-1.171544,"eighty":-0.771314,"marketCap":68981264},{"date":"2025-03-28","current":-0.868132,"twenty":-3.619651,"median":-1.167447,"eighty":-0.772558,"marketCap":67133552},{"date":"2025-04-04","current":-0.745081,"twenty":-3.613757,"median":-1.161021,"eighty":-0.771314,"marketCap":57617833},{"date":"2025-04-11","current":-0.722621,"twenty":-3.613374,"median":-1.150809,"eighty":-0.771062,"marketCap":55880983},{"date":"2025-04-17","current":-0.743806,"twenty":-3.611995,"median":-1.149569,"eighty":-0.769606,"marketCap":57519288},{"date":"2025-04-25","current":-0.868132,"twenty":-3.605993,"median":-1.145145,"eighty":-0.769606,"marketCap":67133552},{"date":"2025-05-02","current":-0.876097,"twenty":-3.602943,"median":-1.135315,"eighty":-0.77056,"marketCap":67749456},{"date":"2025-05-09","current":-0.873168,"twenty":-3.597611,"median":-1.128264,"eighty":-0.77066,"marketCap":67522954},{"date":"2025-05-16","current":-0.722039,"twenty":-3.5941,"median":-1.125796,"eighty":-0.77066,"marketCap":68761908},{"date":"2025-05-23","current":-0.780582,"twenty":-3.590118,"median":-1.116393,"eighty":-0.77066,"marketCap":74337198},{"date":"2025-05-30","current":-0.813107,"twenty":-3.574188,"median":-1.116393,"eighty":-0.771062,"marketCap":77434581},{"date":"2025-06-06","current":-0.806602,"twenty":-3.568833,"median":-1.109475,"eighty":-0.771062,"marketCap":76815104},{"date":"2025-06-13","current":-0.793592,"twenty":-3.568833,"median":-1.104156,"eighty":-0.771062,"marketCap":75576151},{"date":"2025-06-20","current":-0.741553,"twenty":-3.556287,"median":-1.086059,"eighty":-0.771062,"marketCap":70620338},{"date":"2025-06-27","current":-0.767573,"twenty":-3.551123,"median":-1.083246,"eighty":-0.771062,"marketCap":73098244}],"updateTime":1751138689724}}}